Danilo B.
- Country
- Italy
- Department
- Department of Woman and Child Health and Public Health
Research Overview
- A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease
- Phase 3 Randomized Study on Safety and Immunogenicity of 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
Data & Insights
Has run more than one trial at 8 of 85 partner sites.
Specializations
Infectious Disease Prevention
This investigator specializes in preventive medicine focusing on serious respiratory infections, particularly in pneumococcal disease and respiratory syncytial virus (RSV) prevention.
- Pneumococcal vaccination strategies
- RSV disease prevention
- Pediatric immunization
The research activities concentrate on immunological responses in pediatric populations.
Pediatric Medicine
The investigator demonstrates particular expertise in protecting vulnerable pediatric populations, including infants and children at increased risk for severe respiratory diseases.
- Infant immunization protocols
- High-risk pediatric populations
- Preventive medicine strategies
Special attention is given to protective measures for both full-term and preterm infants.
Immunology
The investigator's work encompasses immunological response evaluation and antibody-mediated protection against respiratory pathogens.
- Antibody response assessment
- Immunoglobulin analysis
- Vaccine immunogenicity
Focus areas include measuring immune responses and evaluating protective antibody levels.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.